Omaha, Nebraska-based Amber Specialty Pharmacy and Hy-Vee Pharmacy Solutions announce their available services for GlaxoSmithKline’s infused medication sotrovimab. The monoclonal antibody treatment has received the FDA’s emergency use authorization, or EUA, for the treatment of mild to moderate COVID-19 in adults and pediatric patients.
Sotrovimab is authorized to treat patients (12 years of age and older weighing at least 88 pounds) with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death. Sotrovimab marks the third monoclonal antibody treatment that Amber Specialty Pharmacy and Hy-Vee Pharmacy Solutions are able to offer patients.
“Amber Specialty Pharmacy and Hy-Vee Pharmacy Solutions continue to be proud of the role we play in supporting COVID-19 healthcare workers and patients throughout the country. We are committed to positively impacting the communities we serve,” said Kristin Williams, president of Amber Specialty Pharmacy and chief health officer at Hy-Vee Inc.
In addition to sotrovimab, the pharmacy has also been administering Regeneron’s REGEN-COV and Lilly’s bamlanivimab + etesevimab, both of which are also FDA-authorized monoclonal antibody therapies.
Amber Specialty Pharmacy and Hy-Vee Pharmacy Solutions, subsidiaries of Hy-Vee Inc., have 21 locations throughout the U.S. All locations are licensed to administer the antibody treatment and are able to service patients in all 50 states and Puerto Rico.
Amber Specialty Pharmacy locations:
• Atlanta: 3103 Clairmont Road, Suite A, Atlanta, GA 30329;
• Birmingham: 2100 Riverchase Center, Building (Suite) 400, Hoover, AL 35244;
• Boston: 300 Washington St., Suite 150, Newton, MA 02458;
• Buffalo: 520 Ellicott St., Suite 200, Buffalo, NY 14203;
• Charleston: 615 Lee St. E., Charleston, WV 25301;
• Chicago: 1 East Erie St., Suite 630-640, Chicago, IL 60611;
• Dallas (Farmers Branch): 10 Medical Parkway Plaza 3, Suite 107, Farmers Branch, TX 75234;
• Dallas (Richardson): 1301 E. Arapaho Road, Suite 103, Richardson, TX 75081;
• Durham: 629 Davis Drive, Suite #100, Morrisville, NC 27560;
• Houston: 8924 Kirby Drive, Houston, TX 77054;
• Jackson: 3010 Lakeland Cove, Suite I-2, Flowood, MS 39232;
• Omaha: 10004 South 152nd St., Suite A, Omaha, NE 68138;
• Orlando: 6925 Lake Ellenor Drive, Orlando, FL 32809;
• Philadelphia: 323 Norristown Road, Suite 100, Ambler, PA 19002;
• Phoenix: 4602 N. 16th St., Suite 200, Phoenix, AZ 85016;
• Portland: 10 Donald B Dean Dr. #3, South Portland, ME, 04106;
• Providence: 20 Altieri Way, Warwick, RI 02886;
• Richmond: 6605 West Broad St., Suite 110, Richmond, VA 23230; and
• San Bernardino: 328 E. Commercial Road, Unit 103, San Bernardino, CA 92408.
Hy-Vee Pharmacy Solutions locations:
• Des Moines: 215 10th St., Suite 110, Des Moines, IA 50309-3608; and
• Omaha: 10004 S. 152nd St., Suite C, Omaha, NE 68138-3904.
For more information about Amber Specialty Pharmacy and Hy-Vee Pharmacy Solutions’ COVID-19 response, email [email protected].
Amber Specialty Pharmacy headquarters are located in Omaha, Nebraska, with an additional 20 locations throughout the United States and Puerto Rico. Amber Specialty Pharmacy was named the 2020 Specialty Pharmacy of the Year by the National Association of Specialty Pharmacy.
Hy-Vee Pharmacy Solutions is an independent specialty pharmacy operating primarily in Hy-Vee Inc.’s eight state region of Iowa, Illinois, Kansas, Minnesota, Missouri, Nebraska, South Dakota and Wisconsin. Specialized in oral therapies, injectables and home-infusion services, Hy-Vee Pharmacy Solutions provides whole-health care by supporting patients’ medical, emotional, financial and administrative needs.
Hy-Vee Pharmacy Solutions supports a wide range of complex, chronic conditions including oncology, fertility, Crohn’s disease, hormone therapies and more. The Hy-Vee Inc. subsidiary has locations in Des Moines, Iowa and Omaha, Nebraska and is able to service patients in all 50 states.
In September, Amber Specialty Pharmacy and Hy-Vee Pharmacy Solutions launched a COVID-19 response specifically to assist hospitals and physicians throughout the U.S. with dispensing and coordinating administration of Regeneron Monoclonal Antibody Treatment to eligible patients. See story, here.
